Dunhill Financial, LLC

Position in JNJ — Johnson & Johnson

CIK 1948904 LONDON, X0

Position in JNJ

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$930,546

+$60,585 QoQ

Shares Held

3,664

+3.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.50%

of 13F equity value

Holder Rank

#3,075

of 4,664 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Dunhill Financial, LLC holds $6,908,274 across 15 Drug Manufacturers - General names. JNJ ranks #3 (13.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	113,506	$2,733,224
2	ABBV	AbbVie Inc.	4,061	$1,021,910
3	JNJ	Johnson & Johnson This page	3,664	$930,546
4	LLY	ELI LILLY & Co	730	$875,583
5	AMGN	Amgen Inc	1,716	$621,397
6	NVS	Novartis AG	1,303	$204,206
7	BMY	Bristol Myers Squibb Co	1,889	$108,844
8	NVO	Novo Nordisk A S	1,972	$94,537

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$930,546	3,664	+3.0%	Shares	Sole	2026-08-07
2026-03-31	$869,961	3,559	-0.3%	Shares	Sole	2026-05-06
2025-12-31	$738,397	3,568	+0.5%	Shares	Sole	2026-01-29
2025-09-30	$658,426	3,551	+7.6%	Shares	Sole	2025-11-12
2025-06-30	$504,075	3,300	+8.1%	Shares	Sole	2025-08-05
2025-03-31	$506,143	3,052	-6.1%	Shares	Sole	2025-04-21
2024-12-31	$470,015	3,250	+3.4%	Shares	Sole	2025-02-14
2024-09-30	$509,192	3,142	+11.6%	Shares	Sole	2024-11-15
2024-06-30	$411,440	2,815	+105.3%	Shares	Sole	2024-08-09
2024-03-31	$216,878	1,371	+2.9%	Shares	Sole	2024-05-13
2023-12-31	$208,934	1,333	-11.7%	Shares	Sole	2024-02-12
2023-06-30	$249,935	1,510	—	Shares	Sole	2023-08-23
No filing history on record for this holder in this stock.